ARID1A and prostate carcinoma: Besides T cells, polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) have been recently identified as the major immune cell type that leads to an immunosuppressive microenvironment in ARID1A-deficient prostate cancer [77].